Diabetes Alters the Expression and Translocation of the Insulin-Sensitive Glucose Transporters 4 and 8 in the Atria
Overview
Affiliations
Although diabetes has been identified as a major risk factor for atrial fibrillation, little is known about glucose metabolism in the healthy and diabetic atria. Glucose transport into the cell, the rate-limiting step of glucose utilization, is regulated by the Glucose Transporters (GLUTs). Although GLUT4 is the major isoform in the heart, GLUT8 has recently emerged as a novel cardiac isoform. We hypothesized that GLUT-4 and -8 translocation to the atrial cell surface will be regulated by insulin and impaired during insulin-dependent diabetes. GLUT protein content was measured by Western blotting in healthy cardiac myocytes and type 1 (streptozotocin-induced, T1Dx) diabetic rodents. Active cell surface GLUT content was measured using a biotinylated photolabeled assay in the perfused heart. In the healthy atria, insulin stimulation increased both GLUT-4 and -8 translocation to the cell surface (by 100% and 240%, respectively, P<0.05). Upon insulin stimulation, we reported an increase in Akt (Th308 and s473 sites) and AS160 phosphorylation, which was positively (P<0.05) correlated with GLUT4 protein content in the healthy atria. During diabetes, active cell surface GLUT-4 and -8 content was downregulated in the atria (by 70% and 90%, respectively, P<0.05). Akt and AS160 phosphorylation was not impaired in the diabetic atria, suggesting the presence of an intact insulin signaling pathway. This was confirmed by the rescued translocation of GLUT-4 and -8 to the atrial cell surface upon insulin stimulation in the atria of type 1 diabetic subjects. In conclusion, our data suggest that: 1) both GLUT-4 and -8 are insulin-sensitive in the healthy atria through an Akt/AS160 dependent pathway; 2) GLUT-4 and -8 trafficking is impaired in the diabetic atria and rescued by insulin treatment. Alterations in atrial glucose transport may induce perturbations in energy production, which may provide a metabolic substrate for atrial fibrillation during diabetes.
Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond.
Sun Q, Karwi Q, Wong N, Lopaschuk G Cardiovasc Res. 2024; 120(16):1996-2016.
PMID: 39453987 PMC: 11646102. DOI: 10.1093/cvr/cvae231.
Diabetes Causes Significant Alterations in Pulmonary Glucose Transporter Expression.
Campolo A, Maria Z, Lacombe V Metabolites. 2024; 14(5).
PMID: 38786744 PMC: 11123172. DOI: 10.3390/metabo14050267.
Opisthorchis viverrini excretory-secretory products suppress GLUT8 of cholangiocytes.
Kha S, Chaiyadet S, Saichua P, Tangkawatana S, Sripa B, Suttiprapa S Parasitol Res. 2024; 123(3):161.
PMID: 38491300 DOI: 10.1007/s00436-024-08184-3.
Alvarez-Almazan S, Solis-Dominguez L, Duperou-Luna P, Fuerte-Gomez T, Gonzalez-Andrade M, Aranda-Barradas M Int J Mol Sci. 2023; 24(16).
PMID: 37628991 PMC: 10454726. DOI: 10.3390/ijms241612812.
Relevance of Sugar Transport across the Cell Membrane.
Carbo R, Rodriguez E Int J Mol Sci. 2023; 24(7).
PMID: 37047055 PMC: 10094530. DOI: 10.3390/ijms24076085.